Mondrian Investment Partners’s Elevance Health ELV Stock Holding History

Mondrian Investment Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-23,586	Closed	-$5.61M	–	123
2018 Q2	$5.61M	Sell	23,586 -1,323	-5%	-$306K	0.16%	46
2018 Q1	$5.88M	Sell	24,909 -2,240	-8%	-$526K	0.16%	49
2017 Q4	$6.11M	Hold	27,149	–	–	0.15%	51
2017 Q3	$5.16M	Hold	27,149	–	–	0.13%	47
2017 Q2	$5.11M	Buy	27,149 +561	+2%	+$101K	0.15%	47
2017 Q1	$4.4M	Buy	+26,588	New	+$4.23M	0.12%	55
2015 Q2	–	Sell	-200	Closed	-$31K	–	98
2015 Q1	$31K	Hold	200	–	–	﹤0.01%	85
2014 Q4	$25K	Hold	200	–	–	﹤0.01%	88
2014 Q3	$24K	Sell	200 -200	-50%	-$22.9K	﹤0.01%	87
2014 Q2	$43K	Hold	400	–	–	﹤0.01%	75
2014 Q1	$40K	Sell	400 -341,400	-100%	-$30.9M	﹤0.01%	79
2013 Q4	$31.6M	Sell	341,800 -251,300	-42%	-$22.3M	0.44%	57
2013 Q3	$49.6M	Sell	593,100 -163,700	-22%	-$14M	0.73%	40
2013 Q2	$61.9M	Buy	+756,800	New	+$56.6M	0.94%	28

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mondrian Investment Partners's ELV Position: Q3 2018 in Review

Mondrian Investment Partners sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 23,586 shares — an estimated $5.61M sold.

Mondrian Investment Partners first reported a position in ELV in Q2 2013 and held it in 14 quarters. The position peaked at $61.9M in Q2 2013. 947 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

Mondrian Investment Partners reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
Mondrian Investment Partners sold 23,586 Elevance Health shares in Q3 2018, an estimated $5.61M.
Mondrian Investment Partners first reported a position in Elevance Health in Q2 2013 and held it in 14 quarters.
Mondrian Investment Partners's Elevance Health position peaked at $61.9M in Q2 2013.
947 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Mondrian Investment Partners's 13F filing for Q3 2018, filed 1 Nov 2018.